The bioink: A comprehensive review on bioprintablematerials
2017-04-06
org.kosen.entty.User@459619b
이배훈(lbh217)
행사&학회소개
1.
Introduction .................................. ............................ 218
2. Bioinkmaterials ............................ ............................ 218
2.1. Scaffold-based bioinkmaterial ..................... ............................ 218
2.1.1. Hydrogels............................ ............................ 218
2.1.2. Decellularizedmatrix components................. ............................ 228
2.1.3. Microcarriers .......................... ............................ 228
2.2. Scaffold-free bioinkmaterials ....................... ............................ 228
2.2.1. Tissue spheroids......................... ............................ 229
2.2.2. Cell pellet............................ ............................ 229
2.2.3. Tissue strands .......................... ............................ 229
3. Comparative evaluation of bioinkmaterials .................... ............................ 229
3.1. Compatibility with bioprintingmodalities ................. ............................ 229
3.2. Bioprintability .............................. ............................ 229
3.3. Cell viability and proliferation....................... ............................ 230
3.4. Biomimicry ............................... ............................ 230
3.5. Resolution................................ ............................ 231
3.6. Affordability............................... ............................ 231
3.7. Scalability................................ ............................ 231
3.8. Practicality ............................... ............................ 231
3.9. Mechanical and structural integrity .................... ............................ 231
3.10. Bioprinting and post-bioprinting incubation time ............. ............................ 231
3.11. Tissue fusion and formation post-implantation............... ............................ 231
3.12. Degradability ............................... ........................... 232
3.13. Commercial availability .......................... ........................... 232
3.14.
Immunogenicity.............................. ........................... 232
3.15. Applications ............................... ........................... 232
4. Limitations .................................... ........................... 232
5. Future directions ................................. ........................... 233
6. Summary..................................... ........................... 235
7. Acknowledgements ................................ ........................... 235
References....................................... ........................... 235
Introduction .................................. ............................ 218
2. Bioinkmaterials ............................ ............................ 218
2.1. Scaffold-based bioinkmaterial ..................... ............................ 218
2.1.1. Hydrogels............................ ............................ 218
2.1.2. Decellularizedmatrix components................. ............................ 228
2.1.3. Microcarriers .......................... ............................ 228
2.2. Scaffold-free bioinkmaterials ....................... ............................ 228
2.2.1. Tissue spheroids......................... ............................ 229
2.2.2. Cell pellet............................ ............................ 229
2.2.3. Tissue strands .......................... ............................ 229
3. Comparative evaluation of bioinkmaterials .................... ............................ 229
3.1. Compatibility with bioprintingmodalities ................. ............................ 229
3.2. Bioprintability .............................. ............................ 229
3.3. Cell viability and proliferation....................... ............................ 230
3.4. Biomimicry ............................... ............................ 230
3.5. Resolution................................ ............................ 231
3.6. Affordability............................... ............................ 231
3.7. Scalability................................ ............................ 231
3.8. Practicality ............................... ............................ 231
3.9. Mechanical and structural integrity .................... ............................ 231
3.10. Bioprinting and post-bioprinting incubation time ............. ............................ 231
3.11. Tissue fusion and formation post-implantation............... ............................ 231
3.12. Degradability ............................... ........................... 232
3.13. Commercial availability .......................... ........................... 232
3.14.
Immunogenicity.............................. ........................... 232
3.15. Applications ............................... ........................... 232
4. Limitations .................................... ........................... 232
5. Future directions ................................. ........................... 233
6. Summary..................................... ........................... 235
7. Acknowledgements ................................ ........................... 235
References....................................... ........................... 235
보고서작성신청
3D 프린팅 기술이 건축/제조/바이오 영역까지 확대되며 급속하게 발전을 하고 있습니다. 세포을 포함한 조직/기관을 프린팅할 수 바이오 프린팅 기술은 환자에게 맞춤형 치료를 가능하게 할 수 있는 희망을 주고 있습니다. 한편 3D 프린팅에서 세포를 프린팅할 수 있는 바이오잉크들의 개발은 프린팅 기술 과 더불어 빠르게 발전하고 있습니다. 본리뷰는 기존의 바이오잉크들의 인쇄적성, 생체적합성 등 물리, 화학적, 생화확적 특성들을 설명하고 있어 바이오 프린팅에 종사하고 있는 연구자들에게 좋은 지침이 될 것 으로 사려됩니다.